Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis
Public ClinicalTrials.gov record NCT04292223. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 16-Week Open-Label Study of the Effects of Treatment With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis
Study identification
- NCT ID
- NCT04292223
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- ACADIA Pharmaceuticals Inc.
- Industry
- Enrollment
- 29 participants
Conditions and interventions
Conditions
Interventions
- Pimavanserin Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 9, 2020
- Primary completion
- Apr 25, 2022
- Completion
- Apr 25, 2022
- Last update posted
- Jan 13, 2025
2020 – 2022
United States locations
- U.S. sites
- 18
- U.S. states
- 11
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Movement Disorders Center of Arizona | Scottsdale | Arizona | 85258 | — |
| Neurology Center of North Orange County | Fullerton | California | 92835 | — |
| Premier Clinical Research Institute, Inc. | Miami | Florida | 33122 | — |
| Global Health Research Center, Inc. | Miami Lakes | Florida | 33016 | — |
| Quantum Laboratories, Inc. | Pompano Beach | Florida | 33064 | — |
| Parkinson's Disease Treatment Center of Southwest Florida | Port Charlotte | Florida | 33980 | — |
| Accel Research Sites - Brain and Spine Institute | Port Orange | Florida | 32127 | — |
| Infinity Clinical Research, LLC | Sunrise | Florida | 33351 | — |
| Premiere Research Institute at Palm Beach Neurology | West Palm Beach | Florida | 33407 | — |
| AU Movement and Memory Disorders | Augusta | Georgia | 30912 | — |
| Maine Medical Partners Neurology | Scarborough | Maine | 04074 | — |
| Wentworth Health Partners Coastal Neurology Services | Dover | New Hampshire | 03820 | — |
| Bio Behavioral Health | Toms River | New Jersey | 08755 | — |
| Neurology Diagnostics, Inc. | Dayton | Ohio | 45459 | — |
| The Orthopedic Foundation | New Albany | Ohio | 43054 | — |
| Central States Research | Tulsa | Oklahoma | 74136 | — |
| KCA Neurology | Franklin | Tennessee | 37067 | — |
| Neurological Associates of North Texas | Dallas | Texas | 75218 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04292223, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 13, 2025 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04292223 live on ClinicalTrials.gov.